Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?

Alzheimer’s disease (AD) is the most common cause of dementia worldwide and is characterised pathologically by the accumulation of amyloid beta and tau protein aggregates. Currently, there are no approved disease modifying therapies for clearance of either of these proteins from the brain of people...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Simon M., Barnes, Katy, De Marco, Matteo, Shaw, Pamela J., Ferraiuolo, Laura, Blackburn, Daniel J., Venneri, Annalena, Mortiboys, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827030/
https://www.ncbi.nlm.nih.gov/pubmed/33440662
http://dx.doi.org/10.3390/biomedicines9010063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827030/
https://www.ncbi.nlm.nih.gov/pubmed/33440662
http://dx.doi.org/10.3390/biomedicines9010063

Ejemplares similares